Dendreon

Dendreon: Medicare will cover more Provenge costs
Yahoo/AP
Mon, 11/21/11 - 11:43 am
Dendreon
Medicare
Provenge
prostate cancer
Dendreon: New Trial To Examine Understatement Of Provenge Life-Extension Benefits
Seeking Alpha
Fri, 11/18/11 - 11:37 am
Dendreon
Provenge
JNJ
prostate cancer
3 Cancer Immunotherapy Biotechs With Catalysts For 2012
Seeking Alpha
Thu, 11/17/11 - 09:03 am
Alnylam
Dendreon
GSK
Medivation
ImmunoCellular
Novartis
cancer
NewLink Genetics
4 Biotech Stocks Predictive Analysts Expect To Underperform
Seeking Alpha
Mon, 11/14/11 - 05:25 pm
Dendreon
Seattle Genetics
Sunesis
Alnylam
Five Drugs That Own The Prostate Pipeline
Seeking Alpha
Tue, 11/8/11 - 11:00 am
prostate cancer
Dendreon
Provenge
Zytiga
JNJ
Medivation
MVD 3100
Exelixis
cabozantinib
Curtirsen
Teva Pharmaceuticals
OncoGenex
Biotechs And Their Trials By Fire
Seeking Alpha
Mon, 11/7/11 - 11:57 am
MannKind
Keryx
Dendreon
Arena
Biocryst
Aeterna Zentaris
Advanced Cell Technologies
Dendreon, Merck's Hepatitis C Drug: Future Prospects Look Encouraging
Seeking Alpha
Mon, 11/7/11 - 09:25 am
Merck
Dendreon
hepatitis C
Victrelis
Medivation Up 140% In One Day, While Dendreon Gets Quartered
Seeking Alpha
Sat, 11/5/11 - 02:35 pm
Medivation
Dendreon
Provenge
MDV3100
prostate cancer
Dendreon beaten down again on so-so Provenge sales update
Fierce Pharma
Thu, 11/3/11 - 11:37 am
Dendreon
Provenge
prostate cancern
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
All Eyes On Dendreon With Earnings Set For Wednesday
Seeking Alpha
Sun, 10/30/11 - 12:41 pm
Dendreon
earnings
Amgen Is Poised For Continued Success
Seeking Alpha
Wed, 10/26/11 - 09:08 am
Amgen
Pharmasset
Dendreon
Dendreon to amp up DTC support for Provenge
Fierce Pharma
Wed, 10/12/11 - 10:43 am
DTC
Provenge
prostate cancer
Dendreon
Dendreon's Provenge: Some On The Street Doth Protest Too Much
Seeking Alpha
Mon, 10/10/11 - 12:02 pm
Provenge
prostate cancer
Dendreon
Using Options In Speculative Biotech Investing
Seeking Alpha
Mon, 10/10/11 - 11:26 am
Antares Pharma
Aeterna Zentaris
options
Dendreon
BioSante
Keryx
Oncothyreon
Real World Costs Impacting Dendreon's Provenge Sales
Seeking Alpha
Sun, 10/9/11 - 03:55 pm
Dendreon
Provenge
Dendreon's Earnings Announcement Has Investors Looking For A Sectorwide Turnaround
Seeking Alpha
Thu, 10/6/11 - 01:18 pm
earnings
Dendreon
Biotech's Burning Questions for Q3 Earnings
TheStreet.com
Wed, 10/5/11 - 11:01 am
earnings
biotech
Dendreon
Vertex
Human Genome Sciences
Dendreon Revisited: What Management Is Saying About Provenge
Seeking Alpha
Tue, 10/4/11 - 10:44 am
Dendreon
prostate cancer
Provenge
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Achillion
Aeterna Zentaris
Antigenics
Ariad
Amylin
Amarin
BioDelivery Sciences
Cyclacel
Geron
Dendreon
PharmAthene
Zalicus
Human Genome Sciences
Keryx
Peregrine Pharmaceuticals
SIGA technologies
YM BioSciences

Pages